Utilization of Cell Forcibly Expressing Toll-Like Receptor
AssigneeMeiji Co., Ltd.
InventorsTadao Saito, Takeshi Shimosato, Haruki Kitazawa
Life of this patent
Estimating the term…
Loading patent…
AssigneeMeiji Co., Ltd.
InventorsTadao Saito, Takeshi Shimosato, Haruki Kitazawa
Estimating the term…
Cells with forced expression of swine Toll-like receptor 9 (TLR9) are prepared by cloning a TLR9 gene from swine intestinal Peyer's patches. Functional analysis on CpG DNAs using the above cells revealed that swine TLR9 shows a higher recognition ability for a human CpG DNA motif (CpG2006) than for a mouse-specific CpG DNA motif (CpG1826). When the mRNA expression levels in various tissues are compared by the real-time PCR method, it is found out that the mRNA is expressed in Peyer's patches and mesenteric lymph nodes, which play important roles in the intestinal tract immune system, at a level thrice as much as in spleen or more. Thus, the cells that are forced to express an intestinal tract tissue-expressed TLR (for example, TLR9) can be used to identify samples capable of activating the intestinal tract immune system.
A method for assessing whether a test sample activates the intestinal tract immune system, comprising the steps of:
(canceled)
(canceled)
A method for constructing a model intestinal immunocompetent cell, comprising the step of introducing into a cell an expression vector comprising a DNA encoding an intestinal tract tissue-expressed Toll-like receptor.
Use of a cell expressing an intestinal tract tissue-expressed Toll-like receptor as a model intestinal immunocompetent cell.
A cell that expresses an intestinal tract tissue-expressed Toll-like receptor.
Dependencies are inferred from the claim text.